XtalPi, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A

Initial public offerings (IPOs) for innovative, drug-focused biotechs have remained elusive in the Chinese mainland well into the second half of 2024, since the country’s top securities regulator put

The extent to which artificial intelligence (AI) and technology are fundamentally altering the research and development game came through during a panel discussion by Eli Lilly and Company ’s chief i

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Hasten Gets Greater China Rights T